Treatment options and recent research for juvenile dermatomyositis.
The State-of-the-Art of Rheumatology Symposium
Experts from across the nation describe the best clinical approaches to rheumatologic disease management.
Reflections on Living with Lupus, and on Treating It
There are some people whose purpose in life is to entertain. Some of us are fortunate to have them as our patients.
Pinpoint Cognitive Dysfunction in Patients with Lupus
More than 80% of SLE patients experience some type of neurologic manifestation during their disease course. The challenge for rheumatologists and other clinicians lies in appropriately diagnosing any cognitive dysfunctions that accompany lupus and better understanding the causes and risk factors of those dysfunctions. “Cognitive Function in SLE” was the focus of a talk at the 2011 ACR/ARHP Annual Scientific Meeting in November.
The Mystery of IVIg
Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.
Rheum with a View
Panush’s perspectives on selections from the literature
Hydroxychloroquine Retinopathy Still Alive and Well
How rheumatologists are affected by new guidelines from ophthalmology
Reading Rheum
Handpicked Reviews of Contemporary Literature